Steve Schonfeld’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$107K Buy
+35,077
New +$105K ﹤0.01% 2299
2026
Q1
Sell
-13,021
Closed -$47K 2172
2025
Q4
$47K Buy
+13,021
New +$56.8K ﹤0.01% 1884
2024
Q3
Sell
-22,738
Closed -$151K 2012
2024
Q2
$151K Sell
22,738
-78,688
-78% -$581K ﹤0.01% 1845
2024
Q1
$1.03M Sell
101,426
-33,574
-25% -$341K 0.01% 1212
2023
Q4
$1.52M Buy
+135,000
New +$564K 0.01% 893
2023
Q3
Sell
-68,100
Closed -$240K 1744
2023
Q2
$240K Sell
68,100
-206,341
-75% -$926K ﹤0.01% 1486
2023
Q1
$1.16M Buy
+274,441
New +$3.26M 0.01% 896
2022
Q4
Sell
-58,102
Closed -$742K 2558
2022
Q3
$742K Sell
58,102
-120,898
-68% -$1.78M 0.01% 1477
2022
Q2
$2.09M Buy
179,000
+162,500
+985% +$1M 0.02% 733
2022
Q1
$101K Sell
16,500
-1,400
-8% -$10.3K ﹤0.01% 2224
2021
Q4
$164K Sell
17,900
-48,700
-73% -$517K ﹤0.01% 1789
2021
Q3
$754K Buy
+66,600
New +$810K 0.01% 1080
2021
Q2
Sell
-99,834
Closed -$1.41M 1910
2021
Q1
$1.41M Buy
+99,834
New +$1.61M 0.02% 773
2020
Q3
Sell
-34,900
Closed -$374K 1333
2020
Q2
$374K Buy
+34,900
New +$192K 0.01% 910

Other funds holding ALT

Steve Schonfeld's ALT Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Altimmune (ALT) in Q2 2026: 35,077 shares worth $107K. The stake represents ﹤0.01% of the portfolio and ranks #2299 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ALT as recently as Q4 2025.

Steve Schonfeld first reported a position in ALT in Q2 2020 and has held it in 14 quarters since. The position peaked at $2.09M in Q2 2022. 209 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Steve Schonfeld held 35,077 shares of Altimmune worth $107K as of Q2 2026.
  • Altimmune was a new Steve Schonfeld position in Q2 2026.
  • Altimmune made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2299 holding.
  • Steve Schonfeld first reported a position in Altimmune in Q2 2020 and has held it in 14 quarters since.
  • Steve Schonfeld's Altimmune position peaked at $2.09M in Q2 2022.
  • 209 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.